The Honest Answer: It Depends on the Protocol
Different peptides work through different mechanisms on different timelines. Recovery peptides like BPC-157 and TB-500 work on tissue-level processes that take weeks to months. GH secretagogues work on hormonal systems that require months to show measurable changes. There is no universal timeline.
BPC-157 and TB-500 Recovery Protocols
Animal studies suggest tissue healing effects begin within the first few weeks of administration. Patients using recovery protocols for musculoskeletal issues often report subjective improvement in 4-8 weeks. Objective changes in tissue structure take longer. Full protocol duration is typically 8-12 weeks minimum.
GH Secretagogue Protocols
Sermorelin and CJC-1295 + Ipamorelin work on GH pulse patterns that change gradually. IGF-1 levels — the primary objective measure of GH axis activity — typically take 6-12 weeks to show meaningful change. Body composition effects require 3-6 months of consistent use. Physicians check IGF-1 at 90 days to assess response.
Why Monitoring Matters More Than Waiting
A physician-supervised protocol includes checkpoints that allow objective assessment of response — not just patient-reported outcomes. If IGF-1 hasn’t moved at 90 days, the dose may need adjustment. If the patient reports improvement without lab confirmation, the protocol may still be working through mechanisms not captured by IGF-1. Monitoring allows intelligent decisions rather than blind continuation.